Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,043 | -0.2 | 0.87 | 0.34 | 136.39 |
| Oct 2026 | 23,013 | -0.2 | 0.90 | 0.34 | 142.07 |
| Oct 2026 | 21,197 | -0.2 | 0.92 | 0.34 | 145.07 |
| Oct 2026 | 21,127 | -0.2 | 1.00 | 0.34 | 158.34 |
| Oct 2026 | 21,097 | -0.2 | 1.04 | 0.34 | 163.63 |
| Oct 2026 | 21,120 | -0.2 | 1.01 | 0.34 | 159.05 |
| Oct 2026 | 21,167 | -0.2 | 0.96 | 0.34 | 150.70 |
Intelligent Bio Solutions Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,145,802.0 | 1,060,802.0 | 896,774.0 | 1,111,797.0 |
| Net Profit | -3,907,667.0 | -2,862,712.0 | -2,677,590.0 | -2,983,006.0 |
| EPS | — | -1.8 | -2.8 | -3.5 |
Intelligent Bio Solutions Inc. Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 4,215,175.0 | 3,052,532.0 | 3,111,781.0 | 1,256,872.0 | — |
| Net Profit | -12,430,975.0 | -10,568,733.0 | -10,156,759.0 | -10,631,720.0 | — |
| EPS | — | -20.0 | -63.8 | -1,270.0 | -1,368.0 |
Intelligent Bio Solutions Inc. Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 11,941,836.0 | 8,249,786.0 | 13,778,863.0 | 10,354,612.0 | — |
| Total Liabilities | 6,651,010.0 | 5,435,962.0 | 5,595,672.0 | 6,667,614.0 | — |
| Total Equity | 5,510,835.0 | 2,996,136.0 | 8,329,350.0 | 3,798,984.0 | — |
Owes vs Owns
Intelligent Bio Solutions Inc. owed $0.56 for every $1 it owned in Jun 2026, down from $0.64 in Jun 2023.
| Period | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.56× | 0.66× | 0.41× | 0.64× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Intelligent Bio Solutions Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Jun 2026
How it's funded — Jun 2026
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.0 | 1.0 | 6.3 | 1.5 |
| Receivables | 1.7 | 1.7 | 1.0 | 0.8 |
| Inventory | 0.4 | 0.6 | 0.8 | 1.0 |
| Fixed assets (tangible) | 2.0 | 0.3 | 0.9 | 1.2 |
| Intangible assets | 2.8 | 3.8 | 4.4 | 5.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.0 | 0.8 | 0.5 | 0.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.2 | 0.5 | 0.4 |
| Long-term debt | 1.7 | 0.0 | 0.1 | 0.4 |
| Payables | 0.7 | 0.9 | 0.6 | 1.2 |
| Other liabilities | 4.1 | 4.3 | 4.4 | 4.7 |
| Shareholders' equity | 5.3 | 2.8 | 8.2 | 3.7 |
| Net tangible assets | 2.7 | -0.8 | 4.0 | -1.5 |
Intelligent Bio Solutions Inc. Cash Flow
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Operating Activities | -11,927,222.0 | -9,677,313.0 | -9,571,569.0 | -7,377,378.0 | — |
| Investing Activities | -85,573.0 | -231,838.0 | -221,426.0 | -694,142.0 | — |
| Financing Activities | 14,983,706.0 | 4,597,805.0 | 14,560,556.0 | 1,435,323.0 | — |